FDA Webview

Free FDA Notices

Panel to Discuss Southern Hemisphere Influenza Vaccine


Federal Register Notice: FDA will hold a meeting 10/13 of the Vaccines and Related Biological Products Advisory Committee. The committee will meet in open session to discuss and make recommendations on the selection of strains to be included in an influenza virus vaccine for the 2017 southern hemisphere influenza season. The meeting will be held from 1 p.m. to 4:30 p.m. at the FDA White Oak campus in Silver Spring, MD. Contact Sujata Vijh (240) 402-7107, sujata.vijh@fda.hhs.gov or Rosanna Harvey (240) 402-8072, rosanna.harvey@fda.hhs.gov. To view this notice, click here.